YONKERS, NY--(Marketwire - July 14, 2008) - Advanced Viral Research Corp. (OTCBB: ADVR), a cancer therapeutics company, announced today that it has received two Notices of Allowance for patents related to alleviating side effects in patients undergoing treatments for cancer.
